accessibility menu, dialog, popup

UserName
Viewing profile as user:

Pentacenequinones

Polycyclic aromatic hydrocarbon compounds that consist of twenty-two carbon atoms and twenty-four hydrogen atoms linearly fused into five benzene rings, and an even number of carbonyl functional groups.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)

special interests

  • (2)

Search Within Results
Keyword Search:
1 – 2 of 2 results
1

Medchemexpress LLC N-[(6,7-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g/mol | C23H19F3N8O | 10 MG
SDP

SR-3029 is a potent, ATP-competitive small-molecule inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) used as a research reagent in biochemical and cell-based studies. It shows low-nanomolar activity against CK1δ and selective activity against CK1ε, with additional reported activity across certain CDKs and FLT3 in kinase profiling.

  • Potent ATP-competitive inhibition of CK1δ and CK1ε (IC50 44 nM and 260 nM).
  • Ki of 97 nM for both CK1δ and CK1ε.
  • High purity suitable for biochemical and cell-based assays.
  • Available in multiple solid sizes and as DMSO solution for assay preparation.
  • Supplied as a white to pink solid for ease of handling and storage.
  • Molecular weight 480.45 g/mol, facilitating dose calculation.
  • For research use only; not for human or clinical use.

ENCOMPASS_PREFERRED
2

TARGETMOL CHEMICALS INC SR-3029 10MG
SDP

Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. SR-3029 is a potent and highly specific CK1(delta)/CK1(epsilon) inhibitor. purity: 100%

ENCOMPASS_PREFERRED